Company intelligence / Profile preview

China Grand Pharmaceutical and Healthcare Holdings

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

CGP is a major Chinese pharmaceutical company that develops, manufactures, and distributes pharmaceutical products and medical devices. It has significant experience in R&D, regulatory affairs, commercialization within China’s healthcare system, and strategic partnerships with international biotech firms. The company is publicly traded on the Hong Kong Stock Exchange with a market capitalization around $2 billion USD.

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologicMedical device
Industry: Biotech

Partnerships

OncoSec (exclusive license for TAVO™ cancer therapy in Greater China)[7]Sirtex Medical (commercialization alliance)[7]

Beyond the preview

Go deeper on China Grand Pharmaceutical and Healthcare Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on China Grand Pharmaceutical and Healthcare Holdings.

Explore the full profile